1-14 of 14
Francisco J. Esteva
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors

Xuexin He, Jiali Ji, Xiaolan Dai, Aiham Z. Qdaisat, Francisco J. Esteva, Gabriel N. Hortobagyi, Sai-Ching J. Yeung
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (19): 5343–5352.
https://doi.org/10.1158/1078-0432.CCR-20-4162
Published: 01 October 2021
View article titled, Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors
Open the PDF for Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors in another window
Includes: Supplementary data
Journal Articles

Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer

Xuexin He, Jiali Ji, Mei Tian, Francisco J. Esteva, Gabriel N. Hortobagyi, Sai-Ching Jim Yeung
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (24): 7388–7395.
https://doi.org/10.1158/1078-0432.CCR-19-0463
Published: 13 December 2019
View article titled, Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer
Open the PDF for Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers

Mark Jesus M. Magbanua, Lisa A. Carey, Amy DeLuca, Jimmy Hwang, Janet H. Scott, Mothaffar F. Rimawi, Erica L. Mayer, P. Kelly Marcom, Minetta C. Liu, Francisco J. Esteva, John W. Park, Hope S. Rugo
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1098–1105.
https://doi.org/10.1158/1078-0432.CCR-14-1948
Published: 01 March 2015
View article titled, Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers
Open the PDF for Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers in another window
Includes: Supplementary data
Journal Articles

Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer

Lajos Pusztai, Stacy Moulder, Mehmet Altan, Danielle Kwiatkowski, Vicente Valero, Naoto T. Ueno, Francisco J. Esteva, Rony Avritscher, Yuan Qi, Lewis Strauss, Gabriel N. Hortobagyi, Christos Hatzis, W. Fraser Symmans
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (20): 5265–5271.
https://doi.org/10.1158/1078-0432.CCR-14-0800
Published: 14 October 2014
View article titled, Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer
Open the PDF for Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

PEA-15 Inhibits Tumorigenesis in an MDA-MB-468 Triple-Negative Breast Cancer Xenograft Model through Increased Cytoplasmic Localization of Activated Extracellular Signal-Regulated Kinase

Chandra Bartholomeusz, Ana M. Gonzalez-Angulo, Anna Kazansky, Savitri Krishnamurthy, Ping Liu, Linda X. H. Yuan, Fumiyuki Yamasaki, Shuying Liu, Naoki Hayashi, Dongwei Zhang, Francisco J. Esteva, Gabriel N. Hortobagyi, Naoto T. Ueno
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (6): 1802–1811.
https://doi.org/10.1158/1078-0432.CCR-09-1456
Published: 14 March 2010
View article titled, PEA-15 Inhibits Tumorigenesis in an MDA-MB-468 Triple-Negative Breast Cancer Xenograft Model through Increased Cytoplasmic Localization of Activated Extracellular Signal-Regulated Kinase
Open the PDF for PEA-15 Inhibits Tumorigenesis in an MDA-MB-468 Triple-Negative Breast Cancer Xenograft Model through Increased Cytoplasmic Localization of Activated Extracellular Signal-Regulated Kinase in another window
Journal Articles

Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes

Elizabeth A. Mittendorf, Yun Wu, Maurizio Scaltriti, Funda Meric-Bernstam, Kelly K. Hunt, Shaheenah Dawood, Francisco J. Esteva, Aman U. Buzdar, Huiqin Chen, Sameena Eksambi, Gabriel N. Hortobagyi, Jose Baselga, Ana M. Gonzalez-Angulo
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7381–7388.
https://doi.org/10.1158/1078-0432.CCR-09-1735
Published: 30 November 2009
View article titled, Loss of <em>HER2</em> Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
Open the PDF for Loss of <em>HER2</em> Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes in another window
Journal Articles

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer

Dongwei Zhang, Tiffany A. LaFortune, Savitri Krishnamurthy, Francisco J. Esteva, Massimo Cristofanilli, Ping Liu, Anthony Lucci, Balraj Singh, Mien-Chie Hung, Gabriel N. Hortobagyi, Naoto T. Ueno
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (21): 6639–6648.
https://doi.org/10.1158/1078-0432.CCR-09-0951
Published: 02 November 2009
View article titled, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer
Open the PDF for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer

Stacy L. Moulder, W. Fraser Symmans, Daniel J. Booser, Timothy L. Madden, Cindy Lipsanen, Linda Yuan, Abenaa M. Brewster, Massimo Cristofanilli, Kelly K. Hunt, Thomas A. Buchholz, James Zwiebel, Vicente Valero, Gabriel N. Hortobagyi, Francisco J. Esteva
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7909–7916.
https://doi.org/10.1158/1078-0432.CCR-08-1104
Published: 01 December 2008
View article titled, Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer
Open the PDF for Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer in another window
Journal Articles

Preclinical Testing of Clinically Applicable Strategies for Overcoming Trastuzumab Resistance Caused by PTEN Deficiency

Chien-Hsing Lu, Shannon L. Wyszomierski, Ling-Ming Tseng, Meng-Hong Sun, Keng-Hsueh Lan, Christopher L. Neal, Gordon B. Mills, Gabriel N. Hortobagyi, Francisco J. Esteva, Dihua Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5883–5888.
https://doi.org/10.1158/1078-0432.CCR-06-2837
Published: 01 October 2007
View article titled, Preclinical Testing of Clinically Applicable Strategies for Overcoming Trastuzumab Resistance Caused by PTEN Deficiency
Open the PDF for Preclinical Testing of Clinically Applicable Strategies for Overcoming Trastuzumab Resistance Caused by PTEN Deficiency in another window
Journal Articles

The Nuclear Transcription Factor κB/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer

Thomas A. Buchholz, Amit K. Garg, Nitin Chakravarti, Bharat B. Aggarwal, Francisco J. Esteva, Henry M. Kuerer, S. Eva Singletary, Gabriel N. Hortobagyi, Lajos Pusztai, Massimo Cristofanilli, Aysegul A. Sahin
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (23): 8398–8402.
https://doi.org/10.1158/1078-0432.CCR-05-0885
Published: 01 December 2005
View article titled, The Nuclear Transcription Factor κB/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer
Open the PDF for The Nuclear Transcription Factor κB/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer in another window
Journal Articles

Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy

Francisco J. Esteva, Aysegul A. Sahin, Massimo Cristofanilli, Kevin Coombes, Sang-Joon Lee, Joffre Baker, Maureen Cronin, Michael Walker, Drew Watson, Steven Shak, Gabriel N. Hortobagyi
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3315–3319.
https://doi.org/10.1158/1078-0432.CCR-04-1707
Published: 02 May 2005
View article titled, Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy
Open the PDF for Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy in another window
Journal Articles

Jun Activation Domain Binding Protein 1 Expression Is Associated with Low p27Kip1Levels in Node-Negative Breast Cancer

Francisco J. Esteva, Aysegul A. Sahin, George Z. Rassidakis, Linda X. H. Yuan, Terry L. Smith, Ying Yang, Michael Z. Gilcrease, Massimo Cristofanilli, Rita Nahta, Lajos Pusztai, François-Xavier Claret
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5652–5659.
Published: 03 December 2003
View article titled, Jun Activation Domain Binding Protein 1 Expression Is Associated with Low p27<sup>Kip1</sup>Levels in Node-Negative Breast Cancer
Open the PDF for Jun Activation Domain Binding Protein 1 Expression Is Associated with Low p27<sup>Kip1</sup>Levels in Node-Negative Breast Cancer in another window
Journal Articles

HER-2-Targeted Therapy: Lessons Learned and Future Directions

Rita Nahta, Francisco J. Esteva
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5078–5084.
Published: 12 November 2003
View article titled, HER-2-Targeted Therapy: <subtitle>Lessons Learned and Future Directions</subtitle>
Open the PDF for HER-2-Targeted Therapy: <subtitle>Lessons Learned and Future Directions</subtitle> in another window
Journal Articles

Gene Expression Profiles Obtained from Fine-Needle Aspirations of Breast Cancer Reliably Identify Routine Prognostic Markers and Reveal Large-Scale Molecular Differences between Estrogen-negative and Estrogen-positive Tumors

Lajos Pusztai, Mark Ayers, James Stec, Edward Clark, Kenneth Hess, David Stivers, Andrew Damokosh, Nour Sneige, Thomas A. Buchholz, Francisco J. Esteva, Banu Arun, Massimo Cristofanilli, Daniel Booser, Marguerite Rosales, Vicente Valero, Constantine Adams, Gabriel N. Hortobagyi, W. Fraser Symmans
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (7): 2406–2415.
Published: 01 July 2003
View article titled, Gene Expression Profiles Obtained from Fine-Needle Aspirations of Breast Cancer Reliably Identify Routine Prognostic Markers and Reveal Large-Scale Molecular Differences between Estrogen-negative and Estrogen-positive Tumors
Open the PDF for Gene Expression Profiles Obtained from Fine-Needle Aspirations of Breast Cancer Reliably Identify Routine Prognostic Markers and Reveal Large-Scale Molecular Differences between Estrogen-negative and Estrogen-positive Tumors in another window